208
Views
18
CrossRef citations to date
0
Altmetric
Original Article

A theoretical approach for a weighted assessment of the mutagenic potential of nanomaterials

, &
Pages 964-977 | Received 10 Jun 2017, Accepted 18 Sep 2017, Published online: 18 Oct 2017

References

  • Alaraby, M., B. Annangi, R. Marcos, and A. Hernández. 2016. “Drosophila melanogaster as a Suitable In Vivo Model to Determine Potential Side Effects of Nanomaterials: A Review.” Journal of Toxicology and Environmental Health. Part B, Critical Reviews 19: 65–104.
  • Alenius, H., J. Catalán, H. Lindberg, H. Norppa, J. Palomäki, and K. Savolainen. 2014. “Nanomaterials and Human Health.” In Handbook of Nanosafety - Measurement, Exposure and Toxicology, edited by U. Vogel, K. Savolainen, Q. Wu, M. van Tongeren, D. Brouwer, M. Berges, 78–152. Waltham, MA: Academic Press.
  • Arts, J. H., M. Hadi, M. A. Irfan, A. M. Keene, R. Kreiling, D. Lyon, et al. 2015. “A Decision-Making Framework for the Grouping and Testing of Nanomaterials (DF4nanoGrouping).” Regulatory Toxicology and Pharmacology 71: S1–S27.
  • Benameur, L., M. Auffan, M. Cassien, W. Liu, M. Culcasi, H. Rahmouni, et al. 2015. “DNA Damage and Oxidative Stress Induced by CeO2 Nanoparticles in Human Dermal Fibroblasts: Evidence of a Clastogenic Effect as a Mechanism of Genotoxicity.” Nanotoxicology 9: 696–705.
  • Brehm, M., A. Kafka, M. Bamler, R. Kühne, G. Schüürmann, L. Sikk, et al. 2017. “An Integrated Data-Driven Strategy for Safe-by-Design Nanoparticles: The FP7 MODERN Project.” Advances in Experimental Medicine and Biology 947: 257–301.
  • Brusick, D., M. Aardema, L. Kier, D. Kirkland, and G. Williams. 2016. “Genotoxicity Expert Panel Review: Weight of Evidence Evaluation of the Genotoxicity of Glyphosate, Glyphosate-Based Formulations, and Aminomethylphosphonic Acid.” Critical Reviews in Toxicology 46: 56–74.
  • Catalán, J., S. Suhonen, A. Huk, and M. Dusinska. 2014. “Analysis of Nanoparticle-Induced DNA Damage by the Comet Assay.” In Genotoxicity and DNA Repair, edited by L. M. Sierra, I. Gaivão, 241–268. New York: Humana Press.
  • Catalán, J., K. M. Siivola, P. Nymark, H. Lindberg, S. Suhonen, H. Järventaus, et al. 2016. “In Vitro and In Vivo Genotoxic Effects of Straight Versus Tangled Multi-Walled Carbon Nanotubes.” Nanotoxicology 10: 794–806.
  • Clift, M. J., D. O. Raemy, C. Endes, Z. Ali, A. D. Lehmann, C. Brandenberger, et al. 2013. “Can the Ames Test Provide an Insight into Nano-Object Mutagenicity? Investigating the Interaction Between Nano-Objects and Bacteria.” Nanotoxicology 7: 1373–1385.
  • Clift, M. J. D., C. Endes, D. Vanhecke, P. Wick, P. Gehr, R. P. F. Schins, et al. 2014. “A Comparative Study of Different In Vitro Lung Cell Culture Systems to Assess the Most Beneficial Tool for Screening the Potential Adverse Effects of Carbon Nanotubes.” Toxicological Sciences 137: 55–64.
  • Collins, A., N. El Yamani, and M. Dusinska. 2017. “Sensitive Detection of DNA Oxidation Damage Induced by Nanomaterials.” Free Radical Biology & Medicine 107: 69–76.
  • Cordelli, E., J. Keller, P. Eleuteri, P. Villani, L. Ma-Hock, M. Schulz, et al. 2017. “No Genotoxicity in Rat Blood Cells Upon 3- or 6-Month Inhalation Exposure to CeO2 or BaSO4 Nanomaterials.” Mutagenesis 32: 13–22.
  • Deepa, P. V., and K. Rajagopal. 2014. “Nanotoxicology Testing: Potential of Drosophila in Toxicity Assessment of Nanomaterials.” International Journal of Nanoscience and Nanotechnology 5: 25–35.
  • Doak, S. H., B. Manshian, G. J. Jenkins, and N. Singh. 2012. “In Vitro Genotoxicity Testing Strategy for Nanomaterials and the Adaptation of Current OECD Guidelines.” Mutation Research 745: 104–111.
  • Donaldson, K., C. A. Poland, and R. P. Schins. 2010. “Possible Genotoxic Mechanisms of Nanoparticles: Criteria for Improved Test Strategies.” Nanotoxicology 4: 414–420.
  • Dusinska, M., S. Boland, M. Saunders, L. Juillerat-Jeanneret, L. Tran, G. Pojana, et al. 2015. “Towards an Alternative Testing Strategy for Nanomaterials Used in Nanomedicine: Lessons from NanoTEST.” Nanotoxicology 9: 118–132.
  • European Chemicals Agency (ECHA). 2016. Guidance on information requirements and chemical safety assessment. Chapter R7a Endpoint specific guidance. Version 5.0, December 2016. Accessed August 15 2017. https://echa.europa.eu/documents/10162/13632/information_requirements_r7a_en.pdf/e4a2a18f-a2bd-4a04-ac6d-0ea425b2567f
  • European Chemicals Agency (ECHA). 2017a. Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a Endpoint specific guidance, version 2.0, May 2017. Accessed August 15 2017. https://echa.europa.eu/documents/10162/13632/appendix_r7a_nanomaterials_en.pdf/1bef8a8a-6ffa-406a-88cd-fd800ab163ae
  • European Chemicals Agency (ECHA). 2017b. How to prepare registration dossiers that cover nanoforms: best practices, version 1.0, May 2017. Accessed August 15 2017. https://echa.europa.eu/documents/10162/13655/how_to_register_nano_en.pdf/f8c046ec-f60b-4349-492b-e915fd9e3ca0
  • Evans, S. J., M. J. Clift, N. Singh, J. de Oliveira Mallia, M. Burgum, J. W. Wills, et al. 2017. “Critical Review of the Current and Future Challenges Associated with Advanced In Vitro Systems Towards the Study of Nanoparticle (secondary) Genotoxicity.” Mutagenesis 32: 233–241.
  • Fenech, M. 2000. “The In Vitro Micronucleus Technique.” Mutation Research 455: 81–95.
  • George, J. M., M. Magogotya, M. A. Vetten, A. V. Buys, and M. Gulumian. 2017. “ From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays.” Toxicological Sciences 156: 149–166.
  • Godwin, H., C. Nameth, D. Avery, L. L. Bergeson, D. Bernard, E. Beryt, et al. 2015. “Nanomaterial Categorization for Assessing Risk Potential to Facilitate Regulatory Decision-Making.” ACS Nano 9: 3409–3417.
  • Golbamaki, N., B. Rasulev, A. Cassano, R. L. Marchese Robinson, E. Benfenati, J. Leszczynski, and M. T. Cronin. 2015. “Genotoxicity of Metal Oxide Nanomaterials: Review of Recent Data and Discussion of Possible Mechanisms.” Nanoscale 7: 2154–2198.
  • Gonzalez, L., B. J. Sanderson, and M. Kirsch-Volders. 2011. “Adaptations of the In Vitro MN Assay for the Genotoxicity Assessment of Nanomaterials.” Mutagenesis 26: 185–191.
  • Hristozov, D. R., S. Gottardo, A. Critto, and A. Marcomini. 2012. “Risk Assessment of Engineered Nanomaterials: A Review of Available Data and Approaches from a Regulatory Perspective.” Nanotoxicology 6: 880–898.
  • Hunt, G., I. Lynch, F. Cassee, R. D. Handy, T. F. Fernandes, M. Berges, et al. 2013. “Towards a Consensus View On Understanding Nanomaterials Hazards and Managing Exposure: Knowledge Gaps and Recommendations.” Materials (Basel, Switzerland) 6: 1090–1117.
  • Karlsson, H. L. 2010. “The Comet Assay in Nanotoxicology Research.” Analytical and Bioanalytical Chemistry 398: 651–666.
  • Karlsson, H. L., S. Di Bucchianico, A. R. Collins, and M. Dusinska. 2015. “Can the Comet Assay be Used Reliably to Detect Nanoparticle-Induced Genotoxicity?.” Environmental and Molecular Mutagenesis 56: 82–96.
  • Kisin, E. R., A. R. Murray, L. Sargent, D. Lowry, M. Chirila, K. J. Siegrist, et al. 2011. “Genotoxicity of Carbon Nanofibers: Are They Potentially More or Less Dangerous Than Carbon Nanotubes or Asbestos?.” Toxicology and Applied Pharmacology 252: 1–10.
  • Knight, A. W., N. Billinton, P. A. Cahill, A. Scott, J. S. Harvey, K. J. Roberts, et al. 2007. “An Analysis of Results from 305 Compounds Tested with the Yeast RAD54-GFP Genotoxicity Assay (GreenScreen GC)-Including Relative Predictivity of Regulatory Tests and Rodent Carcinogenesis and Performance with Autofluorescent and Coloured Compounds.” Mutagenesis 22: 409–416.
  • Kuempel, E. D., M. C. Jaurand, P. Møller, Y. Morimoto, N. Kobayashi, K. E. Pinkerton, et al. 2017. “Evaluating the Mechanistic Evidence and Key Data Gaps in Assessing the Potential Carcinogenicity of Carbon Nanotubes and Nanofibers in Humans.” Critical Reviews in Toxicology 47: 1–58.
  • Kumar, A., and A. Dhawan. 2013. “Genotoxic and Carcinogenic Potential of Engineered Nanoparticles: An Update.” Archives of Toxicology 87: 1883–1900.
  • Kwon, J. Y., P. Koedrith, and Y. R. Seo. 2014. “Current Investigations into the Genotoxicity of Zinc Oxide and Silica Nanoparticles in Mammalian Models In Vitro and In Vivo: Carcinogenic/Genotoxic Potential, Relevant Mechanisms and Biomarkers, Artifacts, and Limitations.” International Journal of Nanomedicine 9: 271–286.
  • Landsiedel, R., M. D. Kapp, M. Schulz, K. Wiench, and F. Oesch. 2009. “Genotoxicity Investigations on Nanomaterials: Methods, Preparation and Characterization of Test Material, Potential Artifacts and Limitations–Many Questions, Some Answers.” Mutation Research 681: 241–258.
  • Magdolenova, Z., A. Collins, A. Kumar, A. Dhawan, V. Stone, and M. Dusinska. 2014. “Mechanisms of Genotoxicity. A review of In Vitro and In Vivo Studies with Engineered Nanoparticles.” Nanotoxicology 8: 233–278.
  • Moche, H., D. Chevalier, H. Vezin, N. Claude, E. Lorge, and F. Nesslany. 2015. “Genotoxicity of Tungsten Carbide-Cobalt (WC-Co) Nanoparticles In Vitro: Mechanisms-of-Action Studies.” Mutation Research779: 15–22.
  • Murphy, F. A., A. Schinwald, C. A. Poland, and K. Donaldson. 2012. “The Mechanism of Pleural Inflammation by Long Carbon Nanotubes: Interaction of Long Fibres with Macrophages Stimulates Them to Amplify Pro-Inflammatory Responses in Mesothelial Cells.” Particle and Fibre Toxicology 9: 8
  • Msiska, Z., M. Pacurari, A. Mishra, S. S. Leonard, V. Castranova, and V. Vallyathan. 2010. “DNA Double-Strand Breaks by Asbestos, Silica, and Titanium Dioxide: Possible Biomarker of Carcinogenic Potential?.” American Journal of Respiratory Cell and Molecular Biology 43: 210–219.
  • Muller, J., I. Decordier, P. H. Hoet, N. Lombaert, L. Thomassen, F. Huaux, et al. 2008. “Clastogenic and Aneugenic Effects of Multi-Wall Carbon Nanotubes in Epithelial Cells.”Carcinogenesis 29: 427–433.
  • Nakanishi, J., Y. Morimoto, I. Ogura, N. Kobayashi, M. Naya, M. Ema, et al. 2015. “Risk Assessment of the Carbon Nanotube Group.”Risk Analysis 35: 1940–1956.
  • Norppa, H., and G. C. Falck. 2003. “What do Human Micronuclei Contain?.” Mutagenesis 18: 221–233.
  • OECD. 2014. Draft Guidance Document on the use of OECD Test Guidelines on Genotoxicity Testing for Manufactured Nanomaterials. OECD Publishing, Paris. Accessed August 15 2017. http://www.oecd.org/env/ehs/testing/Draft_GD_nano_and_genotox_rev2.pdf
  • OECD. 2016a. Test No. 489: In Vivo Mammalian Alkaline Comet Assay. Paris: OECD Publishing. Accessed August 15 2017. http://dx.doi.org/10.1787/9789264264885-en
  • OECD. 2016b. OECD TG 474: Mammalian Erythrocyte Micronucleus Test. Paris: OECD Publishing. Accessed August 15 2017. http://dx.doi.org/10.1787/9789264224292-en
  • Oomen, A. G., P. M. J. Bos, T. F. Fernandes, K. Hund-Rinke, D. Boraschi, H. J. Byme, et al. 2014. “Concern-Driven Integrated Approaches to Nanomaterial Testing and Assessment: Report of the NanoSafety Cluster Working Group 10.” Nanotoxicology 8: 334–348.
  • Pfuhler, S., R. Elespuru, M. J. Aardema, S. H. Doak, E. Maria Donner, M. Honma, et al. 2013. “Genotoxicity of Nanomaterials: Refining Strategies and Tests for Hazard Identification.” Environmental and Molecular Mutagenesis 54: 229–239.
  • Roller, M. 2011. “In Vitro Genotoxicity Data of Nanomaterials Compared to Carcinogenic Potency of Inorganic Substances After Inhalational Exposure.” Mutation Research 727: 72–85.
  • Sasaki, K., A. Huk, N. El Yamani, N. Tanaka, and M. Dusinska. 2014. “Bhas 42 Cell Transformation Assay for Genotoxic and Non-Genotoxic Carcinogens.” In Genotoxicity and DNA Repair, edited by L. M. Sierra, I. Gaivão, 241–268. New York: Humana Press.
  • Savolainen, K., U. Backman, D. Brouwer, B. Fadeel, T. Fernandes, T. Kuhlbusch, R. Landsiedel, I. Lynch, and L. Pylkkänen.2013. Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations. Accessed August 15 2017. http://www.ttl.fi/en/publications/Electronic_publications/Nanosafety_in_europe_2015-2025/Documents/nanosafety_2015-2025.pdf
  • Snyder-Talkington, B. N., Y. Qian, V. Castranova, and N. L. Guo.2012. “New Perspectives for In Vitro Risk Assessment of Multiwalled Carbon Nanotubes: Application of Coculture and Bioinformatics.” Journal of Toxicology and Environmental Health. Part B, Critical Reviews 15: 468–492.
  • Snyder-Talkington, B. N., D. Schwegler-Berry, V. Castranova, Y. Qian, and N. L. Guo.2013. “Multi-Walled Carbon Nanotubes Induce Human Microvascular Endothelial Cellular Effects in an Alveolar-Capillary Co-Culture with Small Airway Epithelial Cells.” Particle and Fibre Toxicology 10: 35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.